PRINCETON, NJ, October 13, 2022 (GLOBE NEWSWIRE) — Certara, Inc. CERTa global leader in biosimulation, announced today that it will report third quarter 2022 financial results after market close on Monday, November 7thth2022. Management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in the conference call are encouraged to do so Register online. It is recommended to register at least one day in advance. A live and archived webcast of the event will be available on the Investors section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines with proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include more than 2,000 biopharmaceutical companies, academic institutions and regulatory bodies in 62 countries. visit us in www.certara.com.
Investor Relations contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media contact:
Daniel Younger
Cookies CNC
daniel.yunger@kekstcnc.com
